Neutrogena Launch Boosts J&J Skin Care Q3 Revenues
This article was originally published in The Rose Sheet
Executive Summary
Johnson & Johnson's U.S. skin care sales advanced 20.7% to $239 mil. on a reported basis during the third quarter, fueled in part by the performance of Neutrogena Advanced Solutions skin care, the firm said during an Oct. 12 earnings call